Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/9/26 17:00 | 3/5/26 | CGEM | Health | BioPrd | Biological Products, (No Diag | Michaelson Jennifer | MA | O | Chief Sc | 6 | S.dm | -447 | 14.28 | 0 | -31 | 182 | D | |||||||||||||||
2/25/26 17:00 | 2/24/26 | CGEM | Health | BioPrd | Biological Products, (No Diag | Ahmed Nadim | MA | DO | P,CEO | 2 | S | -419 | 14.00 | 0 | -30 | 404 | D | |||||||||||||||
2/25/26 17:00 | 2/24/26 | CGEM | Health | BioPrd | Biological Products, (No Diag | Jones Jeffrey Alan | MA | O | Chief Me | 2 | S | -134 | 14.03 | 0 | -10 | 165 | D | |||||||||||||||
2/25/26 17:00 | 2/24/26 | CGEM | Health | BioPrd | Biological Products, (No Diag | Sumer Jacquelyn L | MA | O | GC | 2 | S | -103 | 14.04 | 0 | -7 | 132 | D | |||||||||||||||
2/23/26 17:00 | 2/20/26 | CGEM | Health | BioPrd | Biological Products, (No Diag | Fenton Mary Kay | MA | O | CFO | 1 | S | -60 | 13.62 | 0 | -4 | 126 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |